Alaska Permanent Fund and Qatar Investment Authority were among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.

Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants based on research at Yale.

Graphcore, whose roots can be traced back to University of Bristol, has added $50m to its coffers thanks to a series C round backed by Bosch, Dell and Samsung.

The ophthalmology-focused precision medicine developer has licensed research from several universities, including Edinburgh.

The deep learning technology developer has raised $40m in a series A+ round from a consortium including Samsung and Ant Financial.

The genetic testing service, spun out from City University of Hong Kong, took its total funding to approximately $53m with a round co-led by Alibaba and Beyond Ventures.

The Johns Hopkins spinout has passed a clinical milestone to trigger the final part of a series B round backed by Osage University Partners.

Stanford spinout Forty Seven is working on an immuno-oncology treatment to fight the overproduction of proteins which inhibit the immune response to cancer.

LimeBike, an app-controlled bike sharing platform, has secured funding from StartX to help it expand to 30 US markets by the end of 2017.